Libra Infusions (DHA:LIBRAINFU) Cash per Share: BDT0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT585.50
View Full Analysis

What is Libra Infusions Cash per Share?

Libra Infusions DHA:LIBRAINFU +0.50% 20 Cash per Share is BDT0.00 as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Libra Infusions's Cash per Share for the quarter that ended in . 20 was BDT0.00.


Libra Infusions  (DHA:LIBRAINFU) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Libra Infusions Cash per Share Related Terms


Libra Infusions Cash per Share Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Cash per Share Chart

Libra Infusions Annual Data
Trend
Cash per Share

Libra Infusions Semi-Annual Data
Cash per Share
DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Libra Infusions's Cash per Share for the fiscal year that ended in . 20 is calculated as:

Libra Infusions's Cash per Share for the quarter that ended in . 20 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of BDT0.00 mean?
Libra Infusions (DHA:LIBRAINFU) has a Cash per Share of BDT0.00 as of . 20. Cash per share is the per-share value of a company's available cash. View historical data for Libra Infusions and its competitors.
Is Libra Infusions' Cash per Share too high?
Libra Infusions' current Cash per Share is BDT0.00. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Cash per Share compare to SECI and LENSF?
Libra Infusions' Cash per Share of BDT0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Libra Infusions and its competitors. Libra Infusions's current Cash per Share is BDT0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Cash per Share of BDT0.00. The current Cash per Share is BDT0.00. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Cash per Share is BDT0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT585.50
Price